Pediatric Cardiology & Heart Surgery
Study finds a heavy impact on outcomes.
Research connects a 12-month growth advantage to primary repair.
Need grows for multispecialty centers and access to heart transplants.
Experts assess current practices and move toward precision medicine.
Standard indomethacin regimen may fail in infants with CYP2C9*2 variant.
New FDA-funded research tackles risk factors for deadly cardiomyopathy.
1 / 5
A promising therapy for a "common killer," heart failure, in children with DMD.
A simple treatment may reduce a widespread and significant complication of heart surgery.